U.S. Orthokeratology Lens Market
完整報告名稱與涵蓋範圍
U.S. Orthokeratology Lens Market Size, Share & Trends Analysis Report By Type (Spherical, Toric), By Disease Indication, By Age Group (6–12 Years, 13–19 Years, 20 Years & Above), By End-use (Optometry Clinics, Ophthalmology Clinics, Hospitals), And Segment Forecasts, 2026 - 2033
報告摘要
U.S. Orthokeratology Lens Market Summary
The U.S. orthokeratology lens market size was valued at USD 29.5 million in 2025 and is projected to grow from USD 29.8 million in 2026 to USD 32.5 million by 2033, at a CAGR of 1.2% from 2026 to 2033. The demand is attributed to the growing prevalence of pediatric myopia and the increasing emphasis on evidence-based myopia management among eye care professionals.
As awareness grows regarding the long-term risks associated with progressive myopia, including retinal detachment, glaucoma, myopic macular degeneration, and cataracts, optometrists are increasingly recommending orthokeratology as an effective intervention to slow axial elongation while providing daytime vision correction without glasses or contact lenses.
High awareness of retinal disorders and an established healthcare infrastructure facilitate the adoption of advanced diagnostic technologies. A recent paper published in Optometry & Vision Science highlights key trends and insights regarding the current state of orthokeratology in the U.S. The findings from the Fitting of Orthokeratology in the United States (FOKUS) survey, conducted with over 500 eye care professionals (ECPs), reveal that 56% of those actively fitting ortho-k lenses expect market growth in the coming year. In addition, 46% of ECPs not currently fitting these lenses plan to begin prescribing them within the next two years.
The increase in screen time due to digital devices also plays a crucial role in market growth. A study by the Vision Council reported that over 60% of adults experience symptoms of digital eye strain, leading to heightened awareness regarding eye care and the importance of effective vision correction methods. This trend is driving more individuals to consider ortho-K lenses as a viable solution.
Demand is also being driven by increasing clinical acceptance and practitioner adoption of orthokeratology in the U.S. The Fitting of Orthokeratology in the United States (FOKUS) survey found that approximately 68% of U.S. practitioners prescribe orthokeratology primarily for myopia management, while 56% expect growth in orthokeratology fitting over the following 12 months. In addition, nearly half of practitioners who are not currently offering orthokeratology indicated plans to begin offering the service, reflecting expanding provider availability and growing confidence in the technology. These trends, combined with advancements in corneal topography, customized lens design, and digital fitting software, are making orthokeratology more accessible and efficient for both clinicians and patients.
U.S. Orthokeratology Lens Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. orthokeratology lens market report based on type, disease indication, age group, and end-use:
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Spherical
• Toric
• Disease Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Nearsightedness (Myopia)
• Astigmatism
• Others
• Age Group Outlook (Revenue, USD Million, 2021 - 2033)
• 6–12 Years
• 13–19 Years
• 20 Years & Above
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Optometry Clinics
• Ophthalmology Clinics
• Hospitals
• Others
授權報價
| Single User License | $3,950 USD |
| Enterprise License | $4,950 USD |
| Corporate User License | $6,950 USD |
目錄 Table of Contents
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Disease Indication
1.2.3. Age Group
1.2.4. End Use
1.2.5. Country scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Disease Indication outlook
2.2.3. Age Group outlook
2.2.4. End Use outlook
2.3. Competitive Insights
Chapter 3. U.S. Orthokeratology Lens Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. Orthokeratology Lens Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. U.S. Orthokeratology Lens Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Orthokeratology Lens Market: Type Movement Analysis
4.3. U.S. Orthokeratology Lens Market by Type Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
4.5. Spherical
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Toric
4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Orthokeratology Lens Market: Disease Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Orthokeratology Lens Market: Disease Indication Movement Analysis
5.3. U.S. Orthokeratology Lens Market by Disease Indication Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
5.5. Nearsightedness (Myopia)
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Astigmatism
5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Others
5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Orthokeratology Lens Market: Age Group Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Orthokeratology Lens Market: Age Group Movement Analysis
6.3. U.S. Orthokeratology Lens Market by Age Group Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
6.5. 6–12 Years
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. 13–19 Years
6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. 20 Years & Above
6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Orthokeratology Lens Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Orthokeratology Lens Market: End Use Movement Analysis
7.3. U.S. Orthokeratology Lens Market by End Use Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
7.5. Optometry Clinics
7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Ophthalmology Clinics
7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Hospitals
7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Others
7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Euclid Vision Corporation
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Product/Service Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. CooperVision
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Product/Service Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. Contex, Inc.
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Product/Service Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. Bausch + Lomb.
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Product/Service Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. Johnson & Johnson
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Product/Service Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. Art Optical Contact Lens, Inc.
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Product/Service Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. WAVE Contact Lens System
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Product/Service Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. TruForm Optics Inc.
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Product/Service Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. AccuLens
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Product/Service Benchmarking
8.2.9.4. Strategic Initiatives
圖表清單 List of Tables & Figures
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. orthokeratology lens market, by type, 2021 - 2033 (USD Million)
Table 4. U.S. orthokeratology lens market, by disease indication, 2021 - 2033 (USD Million)
Table 5. U.S. orthokeratology lens market, by age group, 2021 - 2033 (USD Million)
Table 6. U.S. orthokeratology lens market, by end use, 2021 - 2033 (USD Million)
List of Figures
Fig 1. U.S. orthokeratology lens market segmentation
Fig 2. Market research process
Fig 3. Data triangulation techniques
Fig 4. Primary research pattern
Fig 5. Market research approaches
Fig 6. Value-chain-based sizing & forecasting
Fig 7. Market formulation & validation
Fig 8. Market snapshot
Fig 9. Type & disease indication outlook (USD Million)
Fig 10. Age group & end use outlook (USD Million)
Fig 11. Competitive landscape
Fig 12. U.S. orthokeratology lens market dynamics
Fig 13. U.S. orthokeratology lens market: Porter’s five forces analysis
Fig 14. U.S. orthokeratology lens market: PESTLE analysis
Fig 15. U.S. orthokeratology lens market: Type segment dashboard
Fig 16. U.S. orthokeratology lens market: Type market share analysis, 2025 & 2033
Fig 17. Spherical market, 2021 - 2033 (USD Million)
Fig 18. Toric market, 2021 - 2033 (USD Million)
Fig 19. U.S. orthokeratology lens market: Disease indication segment dashboard
Fig 20. U.S. orthokeratology lens market: Disease indication market share analysis, 2025 & 2033
Fig 21. Nearsightedness (Myopia) market, 2021 - 2033 (USD Million)
Fig 22. Astigmatism market, 2021 - 2033 (USD Million)
Fig 23. Others market, 2021 - 2033 (USD Million)
Fig 24. U.S. orthokeratology lens market: Age group segment dashboard
Fig 25. U.S. orthokeratology lens market: Age group market share analysis, 2025 & 2033
Fig 26. 6–12 years market, 2021 - 2033 (USD Million)
Fig 27. 13–19 years market, 2021 - 2033 (USD Million)
Fig 28. 20 years & above market, 2021 - 2033 (USD Million)
Fig 29. U.S. orthokeratology lens market: End use segment dashboard
Fig 30. U.S. orthokeratology lens market: End use market share analysis, 2025 & 2033
Fig 31. Optometry clinics market, 2021 - 2033 (USD Million)
Fig 32. Ophthalmology clinics market, 2021 - 2033 (USD Million)
Fig 33. Hospitals market, 2021 - 2033 (USD Million)
Fig 34. Others market, 2021 - 2033 (USD Million)
Fig 35. Company categorization
Fig 36. Company market position analysis
Fig 37. Strategic framework
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們